30 Minutes to Relief? Real-World Data Say Yes - Takeaways - MDSpire

30 Minutes to Relief? Real-World Data Say Yes

Real-world patient-reported outcomes show high responder rates, favorable tolerability, and consistent satisfaction with hyoscine butylbromide plus for menstrual pain self-treatment.

  • By

  • Kathryn Wighton

  • January 9, 2026

  • 3 min

Share

  • 1

    Hyoscine butylbromide Plus tablets significantly reduced menstrual pain, with relief reported within a median of 30 minutes.

  • 2

    91% of patients achieved a clinically meaningful response within 4 hours, with a mean pain reduction of 4 points on the NRS.

  • 3

    The study involved 972 women, primarily experiencing moderate to severe pain, and assessed pain at multiple time points post-dose.

  • 4

    More than 90% of patients expressed satisfaction with the treatment, and symptom prevalence decreased from 96% to 70% at 4 hours.

  • 5

    The study was observational, had limitations including a small primary cohort, and was funded by Opella, with some authors affiliated with the company.

Original Source(s)

30 Minutes to Relief? Real-World Data Say Yes

  • by Kathryn Wighton

  • January 9, 2026

Related Content

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.

CGM Shows Potential for Diagnosing Diabetes in Pregnancy

Early glucose patterns may help identify risk, but evidence doesn't support replacing standard testing.

Top 10 States With Rising Demand for Physicians

These 10 states report physician shortages, projected physician supply gaps, or physician-to-population ratios below national benchmarks.